Axon Enterprise
AXON
#509
Rank
A$69.20 B
Marketcap
A$871.15
Share price
-1.24%
Change (1 day)
-10.26%
Change (1 year)

Earnings for Axon Enterprise (AXON)

Earnings in 2025 (TTM): A$0.37 Billion

According to Axon Enterprise 's latest financial reports the company's current earnings are A$2.55 Billion. In 2024 the company made an earning of A$0.57 Billion, an increase over its 2023 earnings that were of A$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Axon Enterprise from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.37 B-34.97%
2024 A$0.57 B147.92%
2023 A$0.23 B68.08%
2022 A$0.13 B-155.47%
2021 -A$0.26 Billion1088.15%
2020 -A$21.12 Million121.3%
2019 -A$9.55 Million-125.74%
2018 A$37.06 M90.75%
2017 A$19.43 M-59.11%
2016 A$47.52 M-9.86%
2015 A$52.72 M8.71%
2014 A$48.5 M10.67%
2013 A$43.82 M43.35%
2012 A$30.57 M-402.97%
2011 -A$10.1 Million33.15%
2010 -A$7.58 Million6315.17%
2009 -A$0.12 Million-100.45%
2008 A$26.06 M-14.25%
2007 A$30.4 M-474.06%
2006 -A$8.13 Million-449.46%
2005 A$2.32 M-94.95%
2004 A$46.06 M307.28%
2003 A$11.31 M1999.86%
2002 A$0.53 M-63.88%
2001 A$1.49 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
XBiotech
XBIT
-A$42.9 Million-112.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-A$0.12 Billion-133.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-A$0.17 Billion-146.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$1.30 B 268.45%๐Ÿ‡บ๐Ÿ‡ธ USA